Microplate fill-height optical cancellation

Microplate fill-height optical cancellation is the cancellation between dilution and increasing light-path length when a fixed dissolved amount is measured vertically through an ideal parallel-sided microplate well. It is a geometric limit of the Beer-Lambert law, not a general guarantee that changing liquid volume leaves a microplate reader signal unchanged.

Let $n$ be the dissolved amount of formazan, $V$ the solution volume, $S$ the constant internal area perpendicular to the beam and $h=V/S$ the liquid height. For a homogeneous solution and a beam traversing that whole height, the background-subtracted absorbance isHere $ϵ$ is the molar absorption coefficient, with units compatible with the units of concentration and length. The formazan optical response depends on amount per illuminated well area in this idealization.

For example, increasing volume from $0.10$ to $0.20\mathrm{c}{\mathrm{m}}^3$ in a well of area $0.50\mathrm{c}{\mathrm{m}}^2$ increases the ideal path from $0.20$ to $0.40\mathrm{cm}$. At fixed dissolved amount, concentration halves and path length doubles, leaving their product unchanged. A fixed-path cuvette would instead show half the product absorbance. If concentration is held fixed while adding more solution to the well, amount increases and the cancellation argument does not apply.

A tapered microplate optical path model shows why well shape matters. Suppose horizontal area at height $z$ is $S(z)=S_0(1+\alpha z)$, with positive area throughout the filled region. ThenFor an outward taper, increasing fill height now reduces the ideal product absorbance at fixed amount. The parallel-sided result is recovered at $\alpha =0$.

This model assumes absorption by dissolved product. A meniscus, an oblique or finite beam, suspended particles, evaporation and instrument-applied microplate path-length correction can change the measured response. The manufacturer's MTT procedure explicitly separates formation of product crystals, dissolution and multiwell measurement.^[ref] A dilution experiment should therefore specify the optical geometry, product recovery and processing rather than treating volume independence as evidence of complete dissolution or unchanged cell viability.

A tapered microplate optical path model accounts for a well's changing horizontal area when relating liquid volume to the vertical light path. The ideal microplate fill-height optical cancellation is exact for parallel sides; a tapered well generally breaks that cancellation even for a fully dissolved, homogeneous dye.

Let the internal area at height $z$ be $S(z)$ and the filled height be $h$. For dissolved amount $n$ distributed uniformly in volume $V(h)$,The last equality uses the Beer-Lambert law for an axial beam that traverses the whole liquid height. Thus the relevant area is the height-averaged area $V(h)/h$, not automatically the bottom area or the area at the meniscus.

For an original area-linear model $S(z)=S_0(1+\alpha z)$, with positive area throughout the liquid,For outward taper $\alpha >0$, raising the fill height at fixed dissolved amount lowers the ideal absorbance. With stipulated $S_0=0.50\mathrm{c}{\mathrm{m}}^2$ and $\alpha =1\mathrm{c}{\mathrm{m}}^{-1}$, heights $0.20$ and $0.40\mathrm{cm}$ correspond to volumes $0.110$ and $0.240\mathrm{c}{\mathrm{m}}^3$. The signal ratio is $1.10/1.20=11/12$, despite unchanged product amount. These are geometric examples, not dimensions assigned to a commercial plate.

Area increasing linearly with height is not an exact conical frustum. If the radius instead follows $r(z)=r_0+\beta z$, integration givesBoth models recover the constant-area limit when taper vanishes. They assume the same molar absorption coefficient and full product recovery at every volume. The manufacturer separates MTT product formation from dissolution and optical measurement.^[ref] Suspended particles, a curved meniscus, an oblique beam or a reader's microplate path-length correction need additional treatment. A change in signal with dilution therefore does not, by itself, establish a change in formazan amount or cell viability.